Blood Cancer Taskforce
The Leukaemia Foundation has established the Blood Cancer Taskforce to help us develop Australia’s First National Strategic Action Plan for Blood Cancer.
The Blood Cancer Taskforce unites Australia’s leading haematologists, researchers, patients and members of the blood cancer ecosystem together for the first time, to provide the blueprint to help tackle the key issues facing the blood cancer community today and into the future.
The Taskforce is co-Chaired by Bill Petch, CEO, Leukaemia Foundation and Professor John Seymour, Director of Cancer Medicine, Clinical Research and Haematology, Peter MacCallum Centre. A full list of members can be found below.
The formation of the Taskforce and development of the National Strategic Action Plan together mark a major milestone for the blood cancer community and will set the national agenda around blood cancer for many years to come.
The Taskforce will meet for the first time at the end of September 2019 and will work together to develop the Action Plan, which will be delivered to Government by June 2020.
|Professor Sanchia Aranda AM||CEO||Cancer Council Australia|
|Dr John Bashford||Director of Research||Icon Group & PCPA|
|Dr Joe Collins||Representative||Lions Club Interational|
|Dr Chris Fraser||Chair Executive Council||ANZCHOG|
|Professor Maher Gandhi||CEO and Director of Clinical Research||Mater Research|
|Professor David Gottlieb||Program Director BMT, Head Cell Therapies||Westmead Hospital|
|Barbie Hartigan||Advocate||Leukaemia Foundation Patient Support|
|Professor Tim Hughes||Cancer Theme Leader||SAHMRI|
|Dr Paul Jackson||General Manager Knowledge Management||Cancer Australia|
|Professor David Joske||Chairperson||Solaris Cancer Care|
|Melanie Kelly||Director||Insight Economics|
|Dr Rishi Kotecha||Consultant Paediatric Oncologist & Clinical Haematologist||Perth Children’s Hospital; ANZCHOG|
|A/Professor Steven Lane||Head of Cancer Program||QIMR Berghofer|
|A/Professor Peter Mollee||Director||Australasian Leukaemia & Lymphoma Group|
|Bill Petch||CEO||Leukaemia Foundation|
|Professor Miles Prince AM||Director, Centre for Blood Cell Therapies Director of Molecular Oncology and Cancer Immunology Epworth||Peter MacCallum Cancer Centre ; Snowdome Foundation; Myeloma Australia|
|Professor Andrew Roberts||Laboratory Head; Joint Leader, Cancer Research and Treatments Theme||Walter and Eliza Hall Institute|
|Professor John Seymour||Director: Cancer Medicine; Director: Department of Haematology||Peter MacCallum Cancer Centre|
|Deborah Sims||Patient and advocate||Blood Cancer Survivor|
|Dr Delaine Smith||CEO||Australasian Leukaemia & Lymphoma Group|
|Elizabeth de Somer||CEO||Medicines Australia|
|Dr Will Stevenson||President||Haematology Society of Australia & New Zealand|
|Richard Vines||Chairman||Rare Cancers Australia|
Developed by the Leukaemia Foundation in consultation with people living with a blood cancer, Leukaemia Foundation support staff, haematology nursing staff and/or Australian clinical haematologists. This content is provided for information purposes only and we urge you to always seek advice from a registered health care professional for diagnosis, treatment and answers to your medical questions, including the suitability of a particular therapy, service, product or treatment in your circumstances. The Leukaemia Foundation shall not bear any liability for any person relying on the materials contained on this website.